Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
New Rogaine foam features Connetics' proprietary VersaFoam delivery technology
2006 OCT 2 -- Connetics Corporation (CNCT)announces the use of its proprietary VersaFoam technology in Pfizer Consumer Healthcare's new Men's Rogaine Foam, available wherever Rogaine is sold.
In January 2006, Pfizer received U.S. Food and Drug Administration approval for Men's Rogaine Foam (minoxidil, 5%) developed under a license from Connetics' VersaFoam technology.
"Rogaine is the most popular topical treatment for hair loss. A Rogaine formulation utilizing Connetics' VersaFoam technology offers patients suffering from hair loss a convenient therapy that absorbs rapidly upon contact with the scalp leaving minimal...
In order to view the entire article, please read your options to the right
